Literature DB >> 22820144

L-DOPA-induced increase in TH-immunoreactive striatal neurons in parkinsonian mice: insights into regulation and function.

Isabel Espadas1, Sanja Darmopil, Eva Vergaño-Vera, Oskar Ortiz, Idaira Oliva, Carlos Vicario-Abejón, Eduardo D Martín, Rosario Moratalla.   

Abstract

Tyrosine hydroxylase (TH)-immunoreactive (ir) neurons have been found in the striatum after dopamine depletion; however, little is known about the mechanism underlying their appearance or their functional significance. We previously showed an increase in striatal TH-ir neurons after L-DOPA treatment in mice with unilateral 6-OHDA lesions in the striatum. In the present study, we further examined the time-course and persistence of the effects of chronic L-DOPA treatment on the appearance and regulation of TH-ir neurons as well as their possible function. We found that the L-DOPA-induced increase in striatal TH-ir neurons is dose-dependent and persists for days after L-DOPA withdrawal, decreasing significantly 10 days after L-DOPA treatment ends. Using hemiparkinsonian D1 receptor knock-out (D1R-/-) and D2 receptor knock-out (D2R-/-) mice, we found that the D1R, but not the D2R, is required for the L-DOPA-induced appearance of TH-ir neurons in the dopamine-depleted striatum. Interestingly, our experiments in aphakia mice, which lack Pitx3 expression in the brain, indicate that the L-DOPA-dependent increase in the number of TH-ir neurons is independent of Pitx3, a transcription factor necessary for the development of mesencephalic dopaminergic neurons. To explore the possible function of L-DOPA-induced TH-ir neurons in the striatum, we examined dopamine overflow and forelimb use in L-DOPA-treated parkinsonian mice. These studies revealed a tight spatio-temporal correlation between the presence of striatal TH-ir neurons, the recovery of electrically stimulated dopamine overflow in the lesioned striatum, and the recovery of contralateral forelimb use with chronic L-DOPA treatment. Our results suggest that the presence of TH-ir neurons in the striatum may underlie the long-duration response to L-DOPA following withdrawal. Promotion of these neurons in the early stages of Parkinson's disease, when dopamine denervation is incomplete, may be beneficial for maintaining motor function.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22820144     DOI: 10.1016/j.nbd.2012.07.012

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  22 in total

1.  L-dopa reverses behavioral deficits in the Pitx3 mouse fetus.

Authors:  Gale A Kleven; Heather M Booth; Marco Voogd; April E Ronca
Journal:  Behav Neurosci       Date:  2014-08-25       Impact factor: 1.912

2.  Are striatal tyrosine hydroxylase interneurons dopaminergic?

Authors:  Harry S Xenias; Osvaldo Ibáñez-Sandoval; Tibor Koós; James M Tepper
Journal:  J Neurosci       Date:  2015-04-22       Impact factor: 6.167

3.  Counteraction by nitric oxide synthase inhibitor of neurochemical alterations of dopaminergic system in 6-OHDA-lesioned rats under L-DOPA treatment.

Authors:  Elaine Del-Bel; Fernando Eduardo Padovan-Neto; Raphael Escorsim Szawka; Célia Aparecida da-Silva; Rita Raisman-Vozari; Janete Anselmo-Franci; Angélica Caroline Romano-Dutra; Francisco Silveira Guimaraes
Journal:  Neurotox Res       Date:  2013-06-27       Impact factor: 3.911

4.  D1 but not D4 dopamine receptors are critical for MDMA-induced neurotoxicity in mice.

Authors:  N Granado; S Ares-Santos; R Moratalla
Journal:  Neurotox Res       Date:  2013-11-21       Impact factor: 3.911

5.  L-DOPA Reverses the Increased Free Amino Acids Tissue Levels Induced by Dopamine Depletion and Rises GABA and Tyrosine in the Striatum.

Authors:  Oscar Solís; Patricia García-Sanz; Antonio S Herranz; María-José Asensio; Rosario Moratalla
Journal:  Neurotox Res       Date:  2016-03-10       Impact factor: 3.911

6.  Nurr1 blocks the mitogenic effect of FGF-2 and EGF, inducing olfactory bulb neural stem cells to adopt dopaminergic and dopaminergic-GABAergic neuronal phenotypes.

Authors:  Eva Vergaño-Vera; Eva Díaz-Guerra; Eva Rodríguez-Traver; Héctor R Méndez-Gómez; Óscar Solís; Jaime Pignatelli; James Pickel; Sang-Hun Lee; Rosario Moratalla; Carlos Vicario-Abejón
Journal:  Dev Neurobiol       Date:  2014-12-10       Impact factor: 3.964

Review 7.  Loss and remodeling of striatal dendritic spines in Parkinson's disease: from homeostasis to maladaptive plasticity?

Authors:  Rosa M Villalba; Yoland Smith
Journal:  J Neural Transm (Vienna)       Date:  2017-05-24       Impact factor: 3.575

8.  Differential Synaptic Remodeling by Dopamine in Direct and Indirect Striatal Projection Neurons in Pitx3-/- Mice, a Genetic Model of Parkinson's Disease.

Authors:  Luz M Suarez; Samuel Alberquilla; Jose R García-Montes; Rosario Moratalla
Journal:  J Neurosci       Date:  2018-02-26       Impact factor: 6.167

9.  Genetic Knockdown of mGluR5 in Striatal D1R-Containing Neurons Attenuates L-DOPA-Induced Dyskinesia in Aphakia Mice.

Authors:  José-Rubén García-Montes; Oscar Solís; Juan Enríquez-Traba; Irene Ruiz-DeDiego; René Drucker-Colín; Rosario Moratalla
Journal:  Mol Neurobiol       Date:  2018-09-27       Impact factor: 5.590

10.  Methamphetamine causes degeneration of dopamine cell bodies and terminals of the nigrostriatal pathway evidenced by silver staining.

Authors:  Sara Ares-Santos; Noelia Granado; Isabel Espadas; Ricardo Martinez-Murillo; Rosario Moratalla
Journal:  Neuropsychopharmacology       Date:  2013-10-30       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.